Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: A population-based cohort study

American Journal of Gastroenterology

Volumn 103, Issue 11, 2008, Pages 2784-2788

  Solaymani Dodaran, Masoud ^a,c   Aithal, Guruprasad P ^b   Card, Tim ^a   West, Joe ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILIARY CIRRHOSIS; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; DATABASES AS TOPIC; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 55349135865     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02092.x     Document Type: Article

References (11)

1. Longo M, Crosignani A, Battezzati PM, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis.[see comment]. Gut 2002 51 : 265 9.
2. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003 362 : 53 61.
3. Jackson H, Solaymani-Dodaran M, Card TR, et al. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: A population-based cohort study. Hepatology 2007 46 : 1131 7.
4. Prince M, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years.[see comment]. Gastroenterology 2002 123 : 1044 51.
5. Crippin JS, Lindor KD, Jorgensen R, et al. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: What is the risk? Hepatology 1992 15 : 858 62.
6. Van Dam GM, Gips CH. Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures. Scand J Gastroenterol 1997 32 : 77 83.
7. Allocca M, Crosignani A, Gritti A, et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 2006 55 : 1795 800.
8. Propst A, Propst T, Lechleitner M, et al. Hypercholesterolemia in primary biliary cirrhosis is no risk factor for atherosclerosis. Dig Dis Sci 1993 38 : 379 80.
9. Chang P-Y, Lu S-C, Su T-C, et al. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res 2004 45 : 2116 22.
10. Sorokin A, Brown JL, Thompson PD. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review. Atherosclerosis 2007 194 : 293 9.
11. Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002 11 : 211 8.